Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8907786 | 1.00 | CA2 (0.33) | CA2 | |
| SCHEMBL8906698 | 0.95 | CA2 (0.30) | CA2 | |
| SCHEMBL8906695 | 0.95 | CA2 (0.30) | CA2 | |
| SCHEMBL6137309 | 0.87 | CA2 (0.37) | CA2 | |
| SCHEMBL6137393 | 0.87 | CA2 (0.37) | CA2 | |
| SCHEMBL1057130 | 0.87 | CA2 (0.37) | CA2 | |
| SCHEMBL1057409 | 0.82 | CA2 (0.34) | CA2 | |
| SCHEMBL9794366 | 0.82 | CA2 (0.34) | CA2 | |
| SCHEMBL6137558 | 0.82 | CA2 (0.34) | CA2 | |
| SCHEMBL9794153 | 0.81 | CA2 (0.33) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5639899-A | TREATMENT OF PERIPHERAL CIRCULATORY DISTURBANCES | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1997-06-17 | — | — | US | disclosed |
| EP-0597095-B1 | PROSTAGLANDIN E1 ANALOGUE | TAISHO PHARMACEUTICAL CO LTD (JP) | 1996-10-30 | — | — | EP | disclosed |
| US-5449815-A | Prostaglandin E1 analogues | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1995-09-12 | — | — | US | disclosed |
| EP-0597095-A1 | PROSTAGLANDIN E1 ANALOGUE | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1994-05-18 | — | — | EP | disclosed |
| EP-0591532-A1 | PROSTAGLANDIN E 1? ANALOGUE | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1994-04-13 | — | — | EP | disclosed |